Rhenman & Partners Asset Management Ab Raised Teva Pharma Ind LTD Adr Repr 1 Share (TEVA) Position; Snap Class A Common Stock (SNAP) Shorts Up By 74.3%

Rhenman & Partners Asset Management Ab increased Teva Pharma Ind Ltd Adr Repr 1 Share (TEVA) stake by 33.33% reported in 2016Q4 SEC filing. Rhenman & Partners Asset Management Ab acquired 90,000 shares as Teva Pharma Ind Ltd Adr Repr 1 Share (TEVA)’s stock declined 20.64%. The Rhenman & Partners Asset Management Ab holds 360,000 shares with $13.05 million value, up from 270,000 last quarter. Teva Pharma Ind Ltd Adr Repr 1 Share now has $31.80 billion valuation. The stock decreased 0.47% or $0.15 on April 28, reaching $31.58. About shares traded. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has declined 38.36% since September 22, 2016 and is downtrending. It has underperformed by 47.87% the S&P500.

Snap Incorporated Class A Common Stock (NYSE:SNAP) had an increase of 74.3% in short interest. SNAP’s SI was 36.71M shares in May as released by FINRA. Its up 74.3% from 21.06 million shares previously. With 30.70 million avg volume, 1 days are for Snap Incorporated Class A Common Stock (NYSE:SNAP)’s short sellers to cover SNAP’s short positions. The stock increased 2.45% or $0.54 on April 28, reaching $22.55. About shares traded. Snap Inc (NYSE:SNAP) has risen 6.00% since April 1, 2017 and is uptrending. It has underperformed by 3.51% the S&P500.

Among 24 analysts covering Teva Pharma (NYSE:TEVA), 12 have Buy rating, 0 Sell and 12 Hold. Therefore 50% are positive. Teva Pharma had 55 analyst reports since July 21, 2015 according to SRatingsIntel. As per Tuesday, January 31, the company rating was maintained by Barclays Capital. The firm has “Buy” rating by Oppenheimer given on Friday, April 7. The firm earned “Buy” rating on Monday, December 7 by Mizuho. The stock of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) earned “Neutral” rating by BTIG Research on Wednesday, November 16. As per Monday, July 18, the company rating was upgraded by HSBC. Argus Research downgraded the shares of TEVA in report on Tuesday, February 28 to “Hold” rating. The stock of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has “Neutral” rating given on Wednesday, November 16 by Mizuho. The firm has “Buy” rating given on Thursday, August 25 by Mizuho. The firm has “Neutral” rating by JP Morgan given on Friday, January 20. On Friday, September 2 the stock rating was upgraded by Oppenheimer to “Outperform”.

Rhenman & Partners Asset Management Ab decreased Achillion Pharmaceuticals Inc (NASDAQ:ACHN) stake by 100,000 shares to 166,000 valued at $686,000 in 2016Q4. It also reduced Chimerix Inc (NASDAQ:CMRX) stake by 150,000 shares and now owns 400,000 shares. Vertex Pharmaceuticals Inc (NASDAQ:VRTX) was reduced too.

Among 29 analysts covering Snap Chat (NYSE:SNAP), 13 have Buy rating, 3 Sell and 13 Hold. Therefore 45% are positive. Snap Chat had 32 analyst reports since March 2, 2017 according to SRatingsIntel. The stock has “Mkt Perform” rating by Raymond James on Wednesday, April 26. Susquehanna initiated the shares of SNAP in report on Friday, March 3 with “Neutral” rating. The rating was initiated by OTR Global with “Positive” on Friday, March 24. Robert W. Baird maintained it with “Buy” rating and $30 target in Thursday, March 30 report. The stock of Snap Inc (NYSE:SNAP) has “Equal Weight” rating given on Wednesday, March 29 by Barclays Capital. The stock of Snap Inc (NYSE:SNAP) earned “Sell” rating by Pivotal Research on Thursday, March 2. The firm earned “Hold” rating on Friday, April 28 by Canaccord Genuity. Loop Capital initiated Snap Inc (NYSE:SNAP) on Tuesday, March 28 with “Hold” rating. Deutsche Bank initiated the stock with “Buy” rating in Monday, March 27 report. The firm earned “Neutral” rating on Thursday, March 23 by Piper Jaffray.

Snap Inc., formerly Snapchat, Inc., is a camera company. The company has market cap of $27.09 billion. The Company’s flagship product, Snapchat, is a camera application that helps people to communicate through short videos and images known as a Snap. It currently has negative earnings. The Firm offers three ways for people to make Snaps: the Snapchat application, Publishers Tools that help its partners to create Publisher Stories, and Spectacles, its sunglasses that make Snaps.